Figures below are as of 25 Jul 2026. GMP is an unofficial, unregulated indicator of grey-market demand and is not investment advice.
| Grey Market Premium (GMP) | ₹35 |
| Estimated listing gain | +5.9% |
| Estimated listing price | ₹625 |
| Issue price | ₹590 |
| Issue size | ₹9275.22 Cr |
| Open date | 29 Jul 2026 |
| Close date | 31 Jul 2026 |
| Listing date | 05 Aug 2026 |
| Listing at | BSE, NSE |
| IPO type | Mainboard IPO |
| Registrar | Kfin Technologies Ltd. |
As of 25 Jul 2026, the grey market premium (GMP) for the Manipal Health Enterprises Ltd. IPO is ₹35, implying an estimated listing gain of about +5.9% and an estimated listing price near ₹625. GMP is unofficial and unregulated — it indicates grey-market sentiment, not a guaranteed listing price.
The Manipal Health Enterprises Ltd. IPO is open for subscription from 29 Jul 2026 to 31 Jul 2026. It is expected to list on 05 Aug 2026.
The Manipal Health Enterprises Ltd. IPO is priced at ₹590 per share, with a total issue size of ₹9275.22 Cr.